1 Department of Cardiothoracic Surgery, The Third Affiliated Hospital to Soochow University, Changzhou 213003, China ; 2 Department of Thoracic Surgery, Zhongshan Hospital, Affiliated to Fudan University, Shanghai 200032, China.
J Thorac Dis. 2014 Jun;6(6):663-7. doi: 10.3978/j.issn.2072-1439.2014.06.29.
The purpose of this study was to explore the indications of radical vedio-assisted mediastinoscopic resection for esophageal cancer.
The data of 109 patients with T1 esophageal cancer who underwent video-assisted mediastinoscopic resection (VAMS group) in Third Affiliated Hospital of Soochow University Hospital from December 2005 to December 2011 were collected in the study for comparison with the 58 patients with T1 esophageal cancer who underwent video-assisted thoracoscopic surgery (VATS group) in Zhongshan Hospital, Fudan University. The perioperative safety and survival were compared between the two groups.
All operations were successful in both groups. One perioperative death was noted in the VATS group. The incidences of post-operative complications were not significantly different between these two groups, whereas the VAMS group was favorable in terms of operative time (P<0.001) and blood loss (P<0.001), and a significantly larger number of chest lymph nodes were dissected in the VATS group compared with the VAMS group (P<0.001). Long-term follow-up showed that the overall survival was not significantly different between these two groups (P=0.876).
T1N0M0 esophageal cancer can be as the indication of VAMS radical resection. VAMS radical resection can be considered as the preferred option for patients with poor pulmonary and cardiac function or a history of pleural disease.
本研究旨在探讨根治性电视纵隔镜切除术治疗食管癌的适应证。
收集 2005 年 12 月至 2011 年 12 月苏州大学附属第三医院 109 例 T1 期食管癌患者行电视纵隔镜切除术(VAMS 组)的临床资料,与同期复旦大学中山医院 58 例行电视胸腔镜手术(VATS 组)的 T1 期食管癌患者进行比较,比较两组患者的围手术期安全性和生存情况。
两组手术均顺利完成,VATS 组有 1 例围手术期死亡。两组患者术后并发症发生率无统计学差异,但 VAMS 组手术时间(P<0.001)和出血量(P<0.001)均优于 VATS 组,VATS 组比 VAMS 组切除的胸内淋巴结数量明显更多(P<0.001)。长期随访显示,两组患者的总体生存率无统计学差异(P=0.876)。
T1N0M0 期食管癌可作为 VAMS 根治性切除术的适应证,对于肺功能和心功能差或有胸膜疾病史的患者,可考虑行 VAMS 根治性切除术。